The Food and Drug Administration posted a Class I classification on Sept. 14 for a recall of a hospital IV start kit containing a skin prep applicator from a lot contaminated with a fungus.
Class I is the FDA's most serious recall category. The agency uses it when there is a reasonable chance of serious health problems or death. The contamination itself has been known since June. The classification is what is new.
The number of affected kits is small. According to the FDA's recall record, 288 units of the Halyard IV START KIT NON-STERILE, reference number KRIV26-02, lot 1658437, were in commerce and were distributed in Nebraska. The recalling firm is AVID Medical, a subsidiary of Owens & Minor, and the recall remains open.
Tracing the Contamination Upstream
The problem traces to a component made by another company. The FDA record states the kits contain BD ChloraPrep Clear 1 mL and FREPP Clear 1.5 mL applicators contaminated with the fungus Aspergillus penicillioides, and it lists the FDA-determined cause as packaging process control. For this kit, AVID identified the affected component as ChloraPrep Clear 1 mL applicators from BD lot 4032183. The applicators are used to clean the skin before procedures, which is why contamination is a serious concern.
The contamination first came to light in June. BD announced it was voluntarily recalling two lots of the applicators nationwide, to the consumer level. BD said the two lots were shipped to distributors and hospitals between March and June 2024.
Some of those applicators had already been packed into prepackaged kits made by other companies, so each kit maker had to issue its own notice. The FDA's early alert on Medline convenience kits shows how the instructions changed. A June 12 Medline notice told customers to label affected kits with a sticker telling staff to remove and discard the affected applicator before use. An Aug. 11 letter changed that, telling customers to destroy the entire kit for the listed items.
AVID followed a similar path. It sent its first recall notice on July 14 and, on Aug. 18, issued an "Urgent Medical Device Recall Update" under a revised strategy. The update asked customers to quarantine affected products, discard the entire kit, and return response forms by Aug. 28.
In August, MedicalDaily reported on the series of convenience kit alerts tied to recalled components and said it would report classifications as they were assigned.
The FDA has described the possible harm. According to the agency's alert, skin prep products contaminated with Aspergillus penicillioides may lead to serious health consequences, including widespread infection, sepsis, and death. If the fungus enters the bloodstream while an IV catheter is placed, the catheter would likely need to be removed, requiring another procedure. An infected surgical site may require medical and surgical treatment and long-term antifungal medication.
No harm has been reported so far. As of Aug. 17, Medline had not reported any serious injuries or deaths linked to the issue, according to the FDA. When BD announced its recall in June, the company said it had not received any reports of adverse events. A Class I classification reflects how serious the potential harm could be, not a count of injuries.
Who Should Pay Attention
For most people, no action is needed. Patients do not choose their IV start kits, and this recall is being handled by manufacturers, distributors, and hospital supply teams.
Hospital and surgery center supply managers, pharmacy staff, and infection prevention teams should check inventory against the recalled lot numbers and follow the manufacturers' instructions. This AVID lot was distributed in Nebraska, although BD's applicator recall was nationwide.
Patients who recently had an IV placed, an injection, or a surgical procedure and who develop fever, chills, redness, swelling, drainage, or increasing pain at the site should contact the clinician who performed the procedure. That is standard advice after any procedure, recall or not. Fungal infections are especially dangerous for people with weakened immune systems, such as transplant recipients, and rapidly worsening symptoms or signs of sepsis need urgent care.
Nobody should postpone surgery, dialysis, chemotherapy, or an emergency visit because of this recall. Cleaning the skin before procedures remains essential to preventing infection, and the vast majority of skin prep products are not affected.
Several questions remain open. The FDA has not published a total count of affected kits across all kit makers, has not classified every related recall, and has not said whether more lots will be added. Whether any infection will be linked to the contaminated lots is unknown. Clinicians and consumers can report problems through the FDA's MedWatch reporting program. MedicalDaily will report additional classifications and any expansion.
Developing Story Timeline
Sept. 14, 2026: The FDA posts a Class I classification for the AVID Medical Halyard IV START KIT NON-STERILE, lot 1658437, covering 288 units distributed in Nebraska.
Aug. 24, 2026: The FDA publishes an early alert on Medline convenience kits containing the recalled applicators, noting no reported serious injuries or deaths as of Aug. 17.
Aug. 18, 2026: AVID Medical issues an urgent recall update under a revised strategy, telling customers to discard entire kits from the affected lot.
Aug. 11, 2026: Medline tells customers to destroy the entire kit for listed items, replacing its earlier sticker instruction.
July 14, 2026: AVID Medical sends its first recall notice.
June 12, 2026: Medline sends its first notice on affected convenience kits.
June 6, 2026: BD announces a nationwide recall of specific ChloraPrep and FREPP applicator lots over fungal contamination.
Key Questions Answered
What is new? On Sept. 14, the FDA posted a Class I classification, its most serious recall category, for an AVID Medical IV start kit containing a recalled skin prep applicator.
What does Class I mean? The FDA uses Class I when there is a reasonable chance that a product will cause serious health problems or death. It reflects potential severity, not reported harm.
How many kits are involved? The FDA record lists 288 units of lot 1658437, distributed in Nebraska. The underlying applicator recall was nationwide and affected kits from more than one kit maker.
Has anyone been hurt? No injuries or deaths have been reported in the FDA's posted information, and BD said in June that it had received no adverse event reports.
Do patients need to do anything? Generally, no. Anyone with fever, redness, swelling, drainage, or worsening pain at a recent procedure site should contact the clinician who performed the procedure.
Who faces the highest risk from fungal infection? People with weakened immune systems, including transplant recipients.
Should anyone delay a procedure? No. Skin cleaning before procedures prevents infection, and the vast majority of skin prep products are not affected.
